The global market for Bio-based Pentylenediamine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

It is an important C5 platform compound. It is a colorless smoky liquid with a smell similar to ammonia. It is easily soluble in water and ethanol.

North American market for Bio-based Pentylenediamine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Bio-based Pentylenediamine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Bio-based Pentylenediamine include Cathay Biotech Inc., Aphena Pharma Solutions, Bio-Tech Pharmacal, Goodwin Biotechnology, Xenon Pharmaceuticals, Nektar Therapeutics, Midas Pharmaceuticals, Kedrion Biopharma, Xcelthera, Anichem, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bio-based Pentylenediamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio-based Pentylenediamine.

The Bio-based Pentylenediamine market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bio-based Pentylenediamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bio-based Pentylenediamine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Bio-based Pentylenediamine Market Report

Report Metric	Details
Report Name	Bio-based Pentylenediamine Market
by Type	Purity Above 99.5% Purity Above 99.9%
by Application	Spinning Engineering Materials Medicine Pesticides Organic Synthesis Others
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Cathay Biotech Inc., Aphena Pharma Solutions, Bio-Tech Pharmacal, Goodwin Biotechnology, Xenon Pharmaceuticals, Nektar Therapeutics, Midas Pharmaceuticals, Kedrion Biopharma, Xcelthera, Anichem, ALC Bio Innovations, ACADIA Pharmaceuticals, AbbVie Inc., Ology Bioservices, QMI - Quality Management, Biomiga, Molecular Targeting Technologies
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bio-based Pentylenediamine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Bio-based Pentylenediamine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Bio-based Pentylenediamine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Bio-based Pentylenediamine Market report?

Ans: The main players in the Bio-based Pentylenediamine Market are Cathay Biotech Inc., Aphena Pharma Solutions, Bio-Tech Pharmacal, Goodwin Biotechnology, Xenon Pharmaceuticals, Nektar Therapeutics, Midas Pharmaceuticals, Kedrion Biopharma, Xcelthera, Anichem, ALC Bio Innovations, ACADIA Pharmaceuticals, AbbVie Inc., Ology Bioservices, QMI - Quality Management, Biomiga, Molecular Targeting Technologies

What are the Application segmentation covered in the Bio-based Pentylenediamine Market report?

Ans: The Applications covered in the Bio-based Pentylenediamine Market report are Spinning, Engineering Materials, Medicine, Pesticides, Organic Synthesis, Others

What are the Type segmentation covered in the Bio-based Pentylenediamine Market report?

Ans: The Types covered in the Bio-based Pentylenediamine Market report are Purity Above 99.5%, Purity Above 99.9%

1 Bio-based Pentylenediamine Market Overview

1.1 Product Definition

1.2 Bio-based Pentylenediamine by Type

1.2.1 Global Bio-based Pentylenediamine Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 Purity Above 99.5%

1.2.3 Purity Above 99.9%

1.3 Bio-based Pentylenediamine by Application

1.3.1 Global Bio-based Pentylenediamine Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.3.2 Spinning

1.3.3 Engineering Materials

1.3.4 Medicine

1.3.5 Pesticides

1.3.6 Organic Synthesis

1.3.7 Others

1.4 Global Market Growth Prospects

1.4.1 Global Bio-based Pentylenediamine Production Value Estimates and Forecasts (2020-2031)

1.4.2 Global Bio-based Pentylenediamine Production Capacity Estimates and Forecasts (2020-2031)

1.4.3 Global Bio-based Pentylenediamine Production Estimates and Forecasts (2020-2031)

1.4.4 Global Bio-based Pentylenediamine Market Average Price Estimates and Forecasts (2020-2031)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Bio-based Pentylenediamine Production Market Share by Manufacturers (2020-2025)

2.2 Global Bio-based Pentylenediamine Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of Bio-based Pentylenediamine, Industry Ranking, 2023 VS 2024

2.4 Global Bio-based Pentylenediamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global Bio-based Pentylenediamine Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of Bio-based Pentylenediamine, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Bio-based Pentylenediamine, Product Offered and Application

2.8 Global Key Manufacturers of Bio-based Pentylenediamine, Date of Enter into This Industry

2.9 Bio-based Pentylenediamine Market Competitive Situation and Trends

2.9.1 Bio-based Pentylenediamine Market Concentration Rate

2.9.2 Global 5 and 10 Largest Bio-based Pentylenediamine Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Bio-based Pentylenediamine Production by Region

3.1 Global Bio-based Pentylenediamine Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global Bio-based Pentylenediamine Production Value by Region (2020-2031)

3.2.1 Global Bio-based Pentylenediamine Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of Bio-based Pentylenediamine by Region (2026-2031)

3.3 Global Bio-based Pentylenediamine Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global Bio-based Pentylenediamine Production Volume by Region (2020-2031)

3.4.1 Global Bio-based Pentylenediamine Production by Region (2020-2025)

3.4.2 Global Forecasted Production of Bio-based Pentylenediamine by Region (2026-2031)

3.5 Global Bio-based Pentylenediamine Market Price Analysis by Region (2020-2025)

3.6 Global Bio-based Pentylenediamine Production and Value, Year-over-Year Growth

3.6.1 North America Bio-based Pentylenediamine Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe Bio-based Pentylenediamine Production Value Estimates and Forecasts (2020-2031)

3.6.3 China Bio-based Pentylenediamine Production Value Estimates and Forecasts (2020-2031)

3.6.4 Japan Bio-based Pentylenediamine Production Value Estimates and Forecasts (2020-2031)

4 Bio-based Pentylenediamine Consumption by Region

4.1 Global Bio-based Pentylenediamine Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global Bio-based Pentylenediamine Consumption by Region (2020-2031)

4.2.1 Global Bio-based Pentylenediamine Consumption by Region (2020-2025)

4.2.2 Global Bio-based Pentylenediamine Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America Bio-based Pentylenediamine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America Bio-based Pentylenediamine Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Bio-based Pentylenediamine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe Bio-based Pentylenediamine Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Bio-based Pentylenediamine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific Bio-based Pentylenediamine Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Bio-based Pentylenediamine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa Bio-based Pentylenediamine Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Bio-based Pentylenediamine Production by Type (2020-2031)

5.1.1 Global Bio-based Pentylenediamine Production by Type (2020-2025)

5.1.2 Global Bio-based Pentylenediamine Production by Type (2026-2031)

5.1.3 Global Bio-based Pentylenediamine Production Market Share by Type (2020-2031)

5.2 Global Bio-based Pentylenediamine Production Value by Type (2020-2031)

5.2.1 Global Bio-based Pentylenediamine Production Value by Type (2020-2025)

5.2.2 Global Bio-based Pentylenediamine Production Value by Type (2026-2031)

5.2.3 Global Bio-based Pentylenediamine Production Value Market Share by Type (2020-2031)

5.3 Global Bio-based Pentylenediamine Price by Type (2020-2031)

6 Segment by Application

6.1 Global Bio-based Pentylenediamine Production by Application (2020-2031)

6.1.1 Global Bio-based Pentylenediamine Production by Application (2020-2025)

6.1.2 Global Bio-based Pentylenediamine Production by Application (2026-2031)

6.1.3 Global Bio-based Pentylenediamine Production Market Share by Application (2020-2031)

6.2 Global Bio-based Pentylenediamine Production Value by Application (2020-2031)

6.2.1 Global Bio-based Pentylenediamine Production Value by Application (2020-2025)

6.2.2 Global Bio-based Pentylenediamine Production Value by Application (2026-2031)

6.2.3 Global Bio-based Pentylenediamine Production Value Market Share by Application (2020-2031)

6.3 Global Bio-based Pentylenediamine Price by Application (2020-2031)

7 Key Companies Profiled

7.1 Cathay Biotech Inc.

7.1.1 Cathay Biotech Inc. Bio-based Pentylenediamine Company Information

7.1.2 Cathay Biotech Inc. Bio-based Pentylenediamine Product Portfolio

7.1.3 Cathay Biotech Inc. Bio-based Pentylenediamine Production, Value, Price and Gross Margin (2020-2025)

7.1.4 Cathay Biotech Inc. Main Business and Markets Served

7.1.5 Cathay Biotech Inc. Recent Developments/Updates

7.2 Aphena Pharma Solutions

7.2.1 Aphena Pharma Solutions Bio-based Pentylenediamine Company Information

7.2.2 Aphena Pharma Solutions Bio-based Pentylenediamine Product Portfolio

7.2.3 Aphena Pharma Solutions Bio-based Pentylenediamine Production, Value, Price and Gross Margin (2020-2025)

7.2.4 Aphena Pharma Solutions Main Business and Markets Served

7.2.5 Aphena Pharma Solutions Recent Developments/Updates

7.3 Bio-Tech Pharmacal

7.3.1 Bio-Tech Pharmacal Bio-based Pentylenediamine Company Information

7.3.2 Bio-Tech Pharmacal Bio-based Pentylenediamine Product Portfolio

7.3.3 Bio-Tech Pharmacal Bio-based Pentylenediamine Production, Value, Price and Gross Margin (2020-2025)

7.3.4 Bio-Tech Pharmacal Main Business and Markets Served

7.3.5 Bio-Tech Pharmacal Recent Developments/Updates

7.4 Goodwin Biotechnology

7.4.1 Goodwin Biotechnology Bio-based Pentylenediamine Company Information

7.4.2 Goodwin Biotechnology Bio-based Pentylenediamine Product Portfolio

7.4.3 Goodwin Biotechnology Bio-based Pentylenediamine Production, Value, Price and Gross Margin (2020-2025)

7.4.4 Goodwin Biotechnology Main Business and Markets Served

7.4.5 Goodwin Biotechnology Recent Developments/Updates

7.5 Xenon Pharmaceuticals

7.5.1 Xenon Pharmaceuticals Bio-based Pentylenediamine Company Information

7.5.2 Xenon Pharmaceuticals Bio-based Pentylenediamine Product Portfolio

7.5.3 Xenon Pharmaceuticals Bio-based Pentylenediamine Production, Value, Price and Gross Margin (2020-2025)

7.5.4 Xenon Pharmaceuticals Main Business and Markets Served

7.5.5 Xenon Pharmaceuticals Recent Developments/Updates

7.6 Nektar Therapeutics

7.6.1 Nektar Therapeutics Bio-based Pentylenediamine Company Information

7.6.2 Nektar Therapeutics Bio-based Pentylenediamine Product Portfolio

7.6.3 Nektar Therapeutics Bio-based Pentylenediamine Production, Value, Price and Gross Margin (2020-2025)

7.6.4 Nektar Therapeutics Main Business and Markets Served

7.6.5 Nektar Therapeutics Recent Developments/Updates

7.7 Midas Pharmaceuticals

7.7.1 Midas Pharmaceuticals Bio-based Pentylenediamine Company Information

7.7.2 Midas Pharmaceuticals Bio-based Pentylenediamine Product Portfolio

7.7.3 Midas Pharmaceuticals Bio-based Pentylenediamine Production, Value, Price and Gross Margin (2020-2025)

7.7.4 Midas Pharmaceuticals Main Business and Markets Served

7.7.5 Midas Pharmaceuticals Recent Developments/Updates

7.8 Kedrion Biopharma

7.8.1 Kedrion Biopharma Bio-based Pentylenediamine Company Information

7.8.2 Kedrion Biopharma Bio-based Pentylenediamine Product Portfolio

7.8.3 Kedrion Biopharma Bio-based Pentylenediamine Production, Value, Price and Gross Margin (2020-2025)

7.8.4 Kedrion Biopharma Main Business and Markets Served

7.8.5 Kedrion Biopharma Recent Developments/Updates

7.9 Xcelthera

7.9.1 Xcelthera Bio-based Pentylenediamine Company Information

7.9.2 Xcelthera Bio-based Pentylenediamine Product Portfolio

7.9.3 Xcelthera Bio-based Pentylenediamine Production, Value, Price and Gross Margin (2020-2025)

7.9.4 Xcelthera Main Business and Markets Served

7.9.5 Xcelthera Recent Developments/Updates

7.10 Anichem

7.10.1 Anichem Bio-based Pentylenediamine Company Information

7.10.2 Anichem Bio-based Pentylenediamine Product Portfolio

7.10.3 Anichem Bio-based Pentylenediamine Production, Value, Price and Gross Margin (2020-2025)

7.10.4 Anichem Main Business and Markets Served

7.10.5 Anichem Recent Developments/Updates

7.11 ALC Bio Innovations

7.11.1 ALC Bio Innovations Bio-based Pentylenediamine Company Information

7.11.2 ALC Bio Innovations Bio-based Pentylenediamine Product Portfolio

7.11.3 ALC Bio Innovations Bio-based Pentylenediamine Production, Value, Price and Gross Margin (2020-2025)

7.11.4 ALC Bio Innovations Main Business and Markets Served

7.11.5 ALC Bio Innovations Recent Developments/Updates

7.12 ACADIA Pharmaceuticals

7.12.1 ACADIA Pharmaceuticals Bio-based Pentylenediamine Company Information

7.12.2 ACADIA Pharmaceuticals Bio-based Pentylenediamine Product Portfolio

7.12.3 ACADIA Pharmaceuticals Bio-based Pentylenediamine Production, Value, Price and Gross Margin (2020-2025)

7.12.4 ACADIA Pharmaceuticals Main Business and Markets Served

7.12.5 ACADIA Pharmaceuticals Recent Developments/Updates

7.13 AbbVie Inc.

7.13.1 AbbVie Inc. Bio-based Pentylenediamine Company Information

7.13.2 AbbVie Inc. Bio-based Pentylenediamine Product Portfolio

7.13.3 AbbVie Inc. Bio-based Pentylenediamine Production, Value, Price and Gross Margin (2020-2025)

7.13.4 AbbVie Inc. Main Business and Markets Served

7.13.5 AbbVie Inc. Recent Developments/Updates

7.14 Ology Bioservices

7.14.1 Ology Bioservices Bio-based Pentylenediamine Company Information

7.14.2 Ology Bioservices Bio-based Pentylenediamine Product Portfolio

7.14.3 Ology Bioservices Bio-based Pentylenediamine Production, Value, Price and Gross Margin (2020-2025)

7.14.4 Ology Bioservices Main Business and Markets Served

7.14.5 Ology Bioservices Recent Developments/Updates

7.15 QMI - Quality Management

7.15.1 QMI - Quality Management Bio-based Pentylenediamine Company Information

7.15.2 QMI - Quality Management Bio-based Pentylenediamine Product Portfolio

7.15.3 QMI - Quality Management Bio-based Pentylenediamine Production, Value, Price and Gross Margin (2020-2025)

7.15.4 QMI - Quality Management Main Business and Markets Served

7.15.5 QMI - Quality Management Recent Developments/Updates

7.16 Biomiga

7.16.1 Biomiga Bio-based Pentylenediamine Company Information

7.16.2 Biomiga Bio-based Pentylenediamine Product Portfolio

7.16.3 Biomiga Bio-based Pentylenediamine Production, Value, Price and Gross Margin (2020-2025)

7.16.4 Biomiga Main Business and Markets Served

7.16.5 Biomiga Recent Developments/Updates

7.17 Molecular Targeting Technologies

7.17.1 Molecular Targeting Technologies Bio-based Pentylenediamine Company Information

7.17.2 Molecular Targeting Technologies Bio-based Pentylenediamine Product Portfolio

7.17.3 Molecular Targeting Technologies Bio-based Pentylenediamine Production, Value, Price and Gross Margin (2020-2025)

7.17.4 Molecular Targeting Technologies Main Business and Markets Served

7.17.5 Molecular Targeting Technologies Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Bio-based Pentylenediamine Industry Chain Analysis

8.2 Bio-based Pentylenediamine Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Bio-based Pentylenediamine Production Mode & Process Analysis

8.4 Bio-based Pentylenediamine Sales and Marketing

8.4.1 Bio-based Pentylenediamine Sales Channels

8.4.2 Bio-based Pentylenediamine Distributors

8.5 Bio-based Pentylenediamine Customer Analysis

9 Bio-based Pentylenediamine Market Dynamics

9.1 Bio-based Pentylenediamine Industry Trends

9.2 Bio-based Pentylenediamine Market Drivers

9.3 Bio-based Pentylenediamine Market Challenges

9.4 Bio-based Pentylenediamine Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

Cathay Biotech Inc.

Aphena Pharma Solutions

Bio-Tech Pharmacal

Goodwin Biotechnology

Nektar Therapeutics

Kedrion Biopharma

ACADIA Pharmaceuticals

AbbVie

Ology Bioservices

Biomiga

Molecular Targeting Technologies

Xenon Pharmaceuticals

Midas Pharmaceuticals

Xcelthera

Anichem

ALC Bio Innovations

QMI - Quality Management

List of Tables

Table 1. Global Bio-based Pentylenediamine Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global Bio-based Pentylenediamine Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global Bio-based Pentylenediamine Production Capacity (Tons) by Manufacturers in 2024

Table 4. Global Bio-based Pentylenediamine Production by Manufacturers (2020-2025) & (Tons)

Table 5. Global Bio-based Pentylenediamine Production Market Share by Manufacturers (2020-2025)

Table 6. Global Bio-based Pentylenediamine Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global Bio-based Pentylenediamine Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of Bio-based Pentylenediamine, Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Bio-based Pentylenediamine as of 2024)

Table 10. Global Market Bio-based Pentylenediamine Average Price by Manufacturers (US$/Ton) & (2020-2025)

Table 11. Global Key Manufacturers of Bio-based Pentylenediamine, Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of Bio-based Pentylenediamine, Product Offered and Application

Table 13. Global Key Manufacturers of Bio-based Pentylenediamine, Date of Enter into This Industry

Table 14. Global Bio-based Pentylenediamine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Bio-based Pentylenediamine Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Bio-based Pentylenediamine Production Value (US$ Million) by Region (2020-2025)

Table 18. Global Bio-based Pentylenediamine Production Value Market Share by Region (2020-2025)

Table 19. Global Bio-based Pentylenediamine Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global Bio-based Pentylenediamine Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global Bio-based Pentylenediamine Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)

Table 22. Global Bio-based Pentylenediamine Production (Tons) by Region (2020-2025)

Table 23. Global Bio-based Pentylenediamine Production Market Share by Region (2020-2025)

Table 24. Global Bio-based Pentylenediamine Production (Tons) Forecast by Region (2026-2031)

Table 25. Global Bio-based Pentylenediamine Production Market Share Forecast by Region (2026-2031)

Table 26. Global Bio-based Pentylenediamine Market Average Price (US$/Ton) by Region (2020-2025)

Table 27. Global Bio-based Pentylenediamine Market Average Price (US$/Ton) by Region (2026-2031)

Table 28. Global Bio-based Pentylenediamine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)

Table 29. Global Bio-based Pentylenediamine Consumption by Region (2020-2025) & (Tons)

Table 30. Global Bio-based Pentylenediamine Consumption Market Share by Region (2020-2025)

Table 31. Global Bio-based Pentylenediamine Forecasted Consumption by Region (2026-2031) & (Tons)

Table 32. Global Bio-based Pentylenediamine Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America Bio-based Pentylenediamine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 34. North America Bio-based Pentylenediamine Consumption by Country (2020-2025) & (Tons)

Table 35. North America Bio-based Pentylenediamine Consumption by Country (2026-2031) & (Tons)

Table 36. Europe Bio-based Pentylenediamine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 37. Europe Bio-based Pentylenediamine Consumption by Country (2020-2025) & (Tons)

Table 38. Europe Bio-based Pentylenediamine Consumption by Country (2026-2031) & (Tons)

Table 39. Asia Pacific Bio-based Pentylenediamine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)

Table 40. Asia Pacific Bio-based Pentylenediamine Consumption by Region (2020-2025) & (Tons)

Table 41. Asia Pacific Bio-based Pentylenediamine Consumption by Region (2026-2031) & (Tons)

Table 42. Latin America, Middle East & Africa Bio-based Pentylenediamine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 43. Latin America, Middle East & Africa Bio-based Pentylenediamine Consumption by Country (2020-2025) & (Tons)

Table 44. Latin America, Middle East & Africa Bio-based Pentylenediamine Consumption by Country (2026-2031) & (Tons)

Table 45. Global Bio-based Pentylenediamine Production (Tons) by Type (2020-2025)

Table 46. Global Bio-based Pentylenediamine Production (Tons) by Type (2026-2031)

Table 47. Global Bio-based Pentylenediamine Production Market Share by Type (2020-2025)

Table 48. Global Bio-based Pentylenediamine Production Market Share by Type (2026-2031)

Table 49. Global Bio-based Pentylenediamine Production Value (US$ Million) by Type (2020-2025)

Table 50. Global Bio-based Pentylenediamine Production Value (US$ Million) by Type (2026-2031)

Table 51. Global Bio-based Pentylenediamine Production Value Market Share by Type (2020-2025)

Table 52. Global Bio-based Pentylenediamine Production Value Market Share by Type (2026-2031)

Table 53. Global Bio-based Pentylenediamine Price (US$/Ton) by Type (2020-2025)

Table 54. Global Bio-based Pentylenediamine Price (US$/Ton) by Type (2026-2031)

Table 55. Global Bio-based Pentylenediamine Production (Tons) by Application (2020-2025)

Table 56. Global Bio-based Pentylenediamine Production (Tons) by Application (2026-2031)

Table 57. Global Bio-based Pentylenediamine Production Market Share by Application (2020-2025)

Table 58. Global Bio-based Pentylenediamine Production Market Share by Application (2026-2031)

Table 59. Global Bio-based Pentylenediamine Production Value (US$ Million) by Application (2020-2025)

Table 60. Global Bio-based Pentylenediamine Production Value (US$ Million) by Application (2026-2031)

Table 61. Global Bio-based Pentylenediamine Production Value Market Share by Application (2020-2025)

Table 62. Global Bio-based Pentylenediamine Production Value Market Share by Application (2026-2031)

Table 63. Global Bio-based Pentylenediamine Price (US$/Ton) by Application (2020-2025)

Table 64. Global Bio-based Pentylenediamine Price (US$/Ton) by Application (2026-2031)

Table 65. Cathay Biotech Inc. Bio-based Pentylenediamine Company Information

Table 66. Cathay Biotech Inc. Bio-based Pentylenediamine Specification and Application

Table 67. Cathay Biotech Inc. Bio-based Pentylenediamine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 68. Cathay Biotech Inc. Main Business and Markets Served

Table 69. Cathay Biotech Inc. Recent Developments/Updates

Table 70. Aphena Pharma Solutions Bio-based Pentylenediamine Company Information

Table 71. Aphena Pharma Solutions Bio-based Pentylenediamine Specification and Application

Table 72. Aphena Pharma Solutions Bio-based Pentylenediamine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 73. Aphena Pharma Solutions Main Business and Markets Served

Table 74. Aphena Pharma Solutions Recent Developments/Updates

Table 75. Bio-Tech Pharmacal Bio-based Pentylenediamine Company Information

Table 76. Bio-Tech Pharmacal Bio-based Pentylenediamine Specification and Application

Table 77. Bio-Tech Pharmacal Bio-based Pentylenediamine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 78. Bio-Tech Pharmacal Main Business and Markets Served

Table 79. Bio-Tech Pharmacal Recent Developments/Updates

Table 80. Goodwin Biotechnology Bio-based Pentylenediamine Company Information

Table 81. Goodwin Biotechnology Bio-based Pentylenediamine Specification and Application

Table 82. Goodwin Biotechnology Bio-based Pentylenediamine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 83. Goodwin Biotechnology Main Business and Markets Served

Table 84. Goodwin Biotechnology Recent Developments/Updates

Table 85. Xenon Pharmaceuticals Bio-based Pentylenediamine Company Information

Table 86. Xenon Pharmaceuticals Bio-based Pentylenediamine Specification and Application

Table 87. Xenon Pharmaceuticals Bio-based Pentylenediamine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 88. Xenon Pharmaceuticals Main Business and Markets Served

Table 89. Xenon Pharmaceuticals Recent Developments/Updates

Table 90. Nektar Therapeutics Bio-based Pentylenediamine Company Information

Table 91. Nektar Therapeutics Bio-based Pentylenediamine Specification and Application

Table 92. Nektar Therapeutics Bio-based Pentylenediamine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. Nektar Therapeutics Main Business and Markets Served

Table 94. Nektar Therapeutics Recent Developments/Updates

Table 95. Midas Pharmaceuticals Bio-based Pentylenediamine Company Information

Table 96. Midas Pharmaceuticals Bio-based Pentylenediamine Specification and Application

Table 97. Midas Pharmaceuticals Bio-based Pentylenediamine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 98. Midas Pharmaceuticals Main Business and Markets Served

Table 99. Midas Pharmaceuticals Recent Developments/Updates

Table 100. Kedrion Biopharma Bio-based Pentylenediamine Company Information

Table 101. Kedrion Biopharma Bio-based Pentylenediamine Specification and Application

Table 102. Kedrion Biopharma Bio-based Pentylenediamine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 103. Kedrion Biopharma Main Business and Markets Served

Table 104. Kedrion Biopharma Recent Developments/Updates

Table 105. Xcelthera Bio-based Pentylenediamine Company Information

Table 106. Xcelthera Bio-based Pentylenediamine Specification and Application

Table 107. Xcelthera Bio-based Pentylenediamine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 108. Xcelthera Main Business and Markets Served

Table 109. Xcelthera Recent Developments/Updates

Table 110. Anichem Bio-based Pentylenediamine Company Information

Table 111. Anichem Bio-based Pentylenediamine Specification and Application

Table 112. Anichem Bio-based Pentylenediamine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 113. Anichem Main Business and Markets Served

Table 114. Anichem Recent Developments/Updates

Table 115. ALC Bio Innovations Bio-based Pentylenediamine Company Information

Table 116. ALC Bio Innovations Bio-based Pentylenediamine Specification and Application

Table 117. ALC Bio Innovations Bio-based Pentylenediamine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 118. ALC Bio Innovations Main Business and Markets Served

Table 119. ALC Bio Innovations Recent Developments/Updates

Table 120. ACADIA Pharmaceuticals Bio-based Pentylenediamine Company Information

Table 121. ACADIA Pharmaceuticals Bio-based Pentylenediamine Specification and Application

Table 122. ACADIA Pharmaceuticals Bio-based Pentylenediamine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 123. ACADIA Pharmaceuticals Main Business and Markets Served

Table 124. ACADIA Pharmaceuticals Recent Developments/Updates

Table 125. AbbVie Inc. Bio-based Pentylenediamine Company Information

Table 126. AbbVie Inc. Bio-based Pentylenediamine Specification and Application

Table 127. AbbVie Inc. Bio-based Pentylenediamine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 128. AbbVie Inc. Main Business and Markets Served

Table 129. AbbVie Inc. Recent Developments/Updates

Table 130. Ology Bioservices Bio-based Pentylenediamine Company Information

Table 131. Ology Bioservices Bio-based Pentylenediamine Specification and Application

Table 132. Ology Bioservices Bio-based Pentylenediamine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 133. Ology Bioservices Main Business and Markets Served

Table 134. Ology Bioservices Recent Developments/Updates

Table 135. QMI - Quality Management Bio-based Pentylenediamine Company Information

Table 136. QMI - Quality Management Bio-based Pentylenediamine Specification and Application

Table 137. QMI - Quality Management Bio-based Pentylenediamine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 138. QMI - Quality Management Main Business and Markets Served

Table 139. QMI - Quality Management Recent Developments/Updates

Table 140. Biomiga Bio-based Pentylenediamine Company Information

Table 141. Biomiga Bio-based Pentylenediamine Specification and Application

Table 142. Biomiga Bio-based Pentylenediamine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 143. Biomiga Main Business and Markets Served

Table 144. Biomiga Recent Developments/Updates

Table 145. Molecular Targeting Technologies Bio-based Pentylenediamine Company Information

Table 146. Molecular Targeting Technologies Bio-based Pentylenediamine Specification and Application

Table 147. Molecular Targeting Technologies Bio-based Pentylenediamine Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 148. Molecular Targeting Technologies Main Business and Markets Served

Table 149. Molecular Targeting Technologies Recent Developments/Updates

Table 150. Key Raw Materials Lists

Table 151. Raw Materials Key Suppliers Lists

Table 152. Bio-based Pentylenediamine Distributors List

Table 153. Bio-based Pentylenediamine Customers List

Table 154. Bio-based Pentylenediamine Market Trends

Table 155. Bio-based Pentylenediamine Market Drivers

Table 156. Bio-based Pentylenediamine Market Challenges

Table 157. Bio-based Pentylenediamine Market Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

Table 161. Authors List of This Report

List of Figures

Figure 1. Product Picture of Bio-based Pentylenediamine

Figure 2. Global Bio-based Pentylenediamine Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global Bio-based Pentylenediamine Market Share by Type: 2024 VS 2031

Figure 4. Purity Above 99.5% Product Picture

Figure 5. Purity Above 99.9% Product Picture

Figure 6. Global Bio-based Pentylenediamine Market Value by Application, (US$ Million) & (2020-2031)

Figure 7. Global Bio-based Pentylenediamine Market Share by Application: 2024 VS 2031

Figure 8. Spinning

Figure 9. Engineering Materials

Figure 10. Medicine

Figure 11. Pesticides

Figure 12. Organic Synthesis

Figure 13. Others

Figure 14. Global Bio-based Pentylenediamine Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Bio-based Pentylenediamine Production Value (US$ Million) & (2020-2031)

Figure 16. Global Bio-based Pentylenediamine Production Capacity (Tons) & (2020-2031)

Figure 17. Global Bio-based Pentylenediamine Production (Tons) & (2020-2031)

Figure 18. Global Bio-based Pentylenediamine Average Price (US$/Ton) & (2020-2031)

Figure 19. Bio-based Pentylenediamine Report Years Considered

Figure 20. Bio-based Pentylenediamine Production Share by Manufacturers in 2024

Figure 21. Global Bio-based Pentylenediamine Production Value Share by Manufacturers (2024)

Figure 22. Bio-based Pentylenediamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. The Global 5 and 10 Largest Players: Market Share by Bio-based Pentylenediamine Revenue in 2024

Figure 24. Global Bio-based Pentylenediamine Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 25. Global Bio-based Pentylenediamine Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 26. Global Bio-based Pentylenediamine Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)

Figure 27. Global Bio-based Pentylenediamine Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 28. North America Bio-based Pentylenediamine Production Value (US$ Million) Growth Rate (2020-2031)

Figure 29. Europe Bio-based Pentylenediamine Production Value (US$ Million) Growth Rate (2020-2031)

Figure 30. China Bio-based Pentylenediamine Production Value (US$ Million) Growth Rate (2020-2031)

Figure 31. Japan Bio-based Pentylenediamine Production Value (US$ Million) Growth Rate (2020-2031)

Figure 32. Global Bio-based Pentylenediamine Consumption by Region: 2020 VS 2024 VS 2031 (Tons)

Figure 33. Global Bio-based Pentylenediamine Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 34. North America Bio-based Pentylenediamine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 35. North America Bio-based Pentylenediamine Consumption Market Share by Country (2020-2031)

Figure 36. U.S. Bio-based Pentylenediamine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 37. Canada Bio-based Pentylenediamine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 38. Europe Bio-based Pentylenediamine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 39. Europe Bio-based Pentylenediamine Consumption Market Share by Country (2020-2031)

Figure 40. Germany Bio-based Pentylenediamine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 41. France Bio-based Pentylenediamine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 42. U.K. Bio-based Pentylenediamine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 43. Italy Bio-based Pentylenediamine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 44. Russia Bio-based Pentylenediamine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 45. Asia Pacific Bio-based Pentylenediamine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 46. Asia Pacific Bio-based Pentylenediamine Consumption Market Share by Region (2020-2031)

Figure 47. China Bio-based Pentylenediamine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 48. Japan Bio-based Pentylenediamine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 49. South Korea Bio-based Pentylenediamine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 50. China Taiwan Bio-based Pentylenediamine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 51. Southeast Asia Bio-based Pentylenediamine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 52. India Bio-based Pentylenediamine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 53. Latin America, Middle East & Africa Bio-based Pentylenediamine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 54. Latin America, Middle East & Africa Bio-based Pentylenediamine Consumption Market Share by Country (2020-2031)

Figure 55. Mexico Bio-based Pentylenediamine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 56. Brazil Bio-based Pentylenediamine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 57. Turkey Bio-based Pentylenediamine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 58. GCC Countries Bio-based Pentylenediamine Consumption and Growth Rate (2020-2031) & (Tons)

Figure 59. Global Production Market Share of Bio-based Pentylenediamine by Type (2020-2031)

Figure 60. Global Production Value Market Share of Bio-based Pentylenediamine by Type (2020-2031)

Figure 61. Global Bio-based Pentylenediamine Price (US$/Ton) by Type (2020-2031)

Figure 62. Global Production Market Share of Bio-based Pentylenediamine by Application (2020-2031)

Figure 63. Global Production Value Market Share of Bio-based Pentylenediamine by Application (2020-2031)

Figure 64. Global Bio-based Pentylenediamine Price (US$/Ton) by Application (2020-2031)

Figure 65. Bio-based Pentylenediamine Value Chain

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions